Ignite Creation Date:
2024-05-06 @ 7:06 PM
Last Modification Date:
2024-10-26 @ 3:00 PM
Study NCT ID:
NCT05891080
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-06-06
First Post:
2023-05-22
Brief Title:
Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer A Randomised Controlled Open-label Phase 2 Trial
Sponsor:
Organization:
Shanghai Pulmonary Hospital Shanghai China